title: Scarring alopecia associated with the epidermal growth factor receptor inhibitor erlotinib.
authors.forename: Donna M
authors.initials: DM
authors.lastname: Hepper
authors.forename: Peggy
authors.initials: P
authors.lastname: Wu
authors.forename: Milan J
authors.initials: MJ
authors.lastname: Anadkat
mesh_terms: D000368:Aged; D000505:Alopecia / Q000139:chemically induced* / Q000473:pathology; D002289:Carcinoma, Non-Small-Cell Lung / Q000556:secondary*; D002921:Cicatrix; D003875:Drug Eruptions / Q000209:etiology*; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D000069347:Erlotinib Hydrochloride; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology; D011799:Quinazolines / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D011799:Quinazolines; D000069347:Erlotinib Hydrochloride; D066246:ErbB Receptors